CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bioventus Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bioventus Inc
4721 Emperor Boulevard
Suite 100
Phone: (919) 474-6700p:919 474-6700 Durham, NC  27703  United States Ticker: BVSBVS
Business Summary
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202312/31/2022YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board William A.Hawkins 69 9/1/2020 9/1/2020
President, Chief Executive Officer, Director Robert E.Claypoole 52 1/10/2024 1/10/2024
Chief Financial Officer, Senior Vice President MarkSingleton 54 3/21/2022 3/21/2022
7 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Cartiheal Ltd. Ariel Israel
Bioness, Inc. 25103 Rye Canyon Loop Valencia CA United States
Misonix Inc 1938 New Hwy FARMINGDALE NY United States
Solsys Medical, LLC 11830 Canon Blvd. Newport News VA United States

Business Names
Business Name
Bioness Europe B.V.
Bioness Inc.
Bioness Neuromodulation Ltd.
15 additional Business Names available in full report.

General Information
Number of Employees: 970 (As of 9/30/2023)
Outstanding Shares: 79,165,540 (As of 2/27/2024)
Shareholders: 193
Stock Exchange: NASD
Federal Tax Id: 810980861
Fax Number: (302) 655-5049


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024